Single-use Bioprocessing Market Size, Share & Trends Report

Single-use Bioprocessing Market Size, Share & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants, Work Equipment), By Workflow (Upstream, Downstream), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-370-6
  • Number of Pages: 170
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2023
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the single-use bioprocessing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for single-use bioprocessing market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of single-use bioprocessing market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Single-use Bioprocessing Market Categorization:

The single-use bioprocessing market was categorized into four segments, namely product (Simple & Peripheral Elements, Apparatus & Plants, Work Equipment), workflow (Upstream Bioprocessing, Fermentation, Downstream Bioprocessing), end-use (Biopharmaceutical Manufacturers, Academic & Clinical Research Institutes), regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Segment Market Methodology:

The single-use bioprocessing market was segmented into product, workflow, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The single-use bioprocessing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Single-use bioprocessing market companies & financials:

The single-use bioprocessing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Sartorius AG - Sartorius AG provides services associated with pharmaceutical products and laboratory equipment. Sartorius Group functions under Sartorius AG. Its business is segmented into two divisions: bioprocess solutions and lab products & services. Its bioprocess solutions business provides products for process control, fluid management, media & buffers, bioreactors & fermentors, and configural single-use system. Through its lab products & services business, it presents products for weighing, liquid handling filtration/purification, lab water purification, quality control, and cell cultivation. This company was established by Florenz Sartorius and its subsidiaries are situated in approximately 30 nations.

  • Danaher - Danaher’s diagnostic and life sciences business functions collectively to provide products and solutions for both disease treatment and life sciences research. Danaher’s life science companies are engaged in creating products for clinical research facilities, government agencies, and academic establishments. It provides filtration, separation, and purification technologies for the biopharmaceutical industry. In August 2015, Danaher concluded the acquisition of Pall Corporation to boost its life sciences business segment. Danaher corporation is situated in Washington D.C., U.S. and was founded in the year 1969. The company has a strength of 80,000+ employees with more than 20 operating subsidiaries and located in more than 60 countries. The company has three business segments: diagnostics, life sciences, environmental, and applied solutions.

  • Pall Corporation - Pall Corporation runs as a subsidiary of Danaher post its acquisition in August 2015. It is involved in designing and selling of products and solutions for purification, separation, and filtration processes. It provides solutions for entities involved in the development of biotech drugs, cell therapies, vaccines, and classic pharmaceuticals. It has global operations in the Americas, Europe & Middle East Africa, and Asia Pacific.

  • Cytiva - Cytiva is headquartered in Massachusetts, U.S. with a strength of 7000 associates across 40 countries and was founded in 1968. Danaher acquired the biopharma business of General Electric Company’s Life science division. In March 2020, this acquisition resulted in the establishment of Cytiva, a standalone operating company within the Danaher Life sciences segment. Cytiva provides solutions in cell culture, chromatography, drug product filing, and SUT.

  • Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. is a publicly held biotechnology company, established after a collaboration between Fisher Scientific and Thermo Electron. Thermo Fisher provides products in life sciences, industrial & applied sciences, and clinical diagnostics. The company has operations in over 50 countries. The Life Technologies Corporation operates as a subsidiary of Thermo Fisher since April 2013. Thermo Fisher Scientific, Inc. attained a large market share in the single-use bioprocessing space via the acquisition of Advanced Scientific and Finesse Solutions in 2015 and 2017, respectively. Patheon and PPD acquired by Thermo Fisher Scientific, Inc. in 2017 and 2021 also expands the company’s portfolio of industry level CDMO and clinical research services. It acquired Affymetrix, Inc. in March 2016. The company offers services via different brands, namely; Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and Pharmaceutical Product Development (PPD).

  • Merck KGaA - Founded in the year 1668 in Darmstadt, Germany with a work force of more than 60,000 employees, the Merck Group is public held company. The Merck group is known as EMD in the U.S. and Canada due to legal reasons. The company segments its market in life science, healthcare and electronics. It has worldwide operations in North America, Europe, Asia, Latin America, Oceania, and Africa. It offers solutions via its different brands, namely Millipore, Sigma Aldrich, BioReliance, SAFC, Milli-Q, Supelco. The life science business segment of the company operates as MilliporeSigma, which is a combination of the Millipore Corporation and Sigma Aldrich acquired in 2010 and 2015, respectively. The BioReliance brand offers the pharma and biopharma manufacturing and testing solutions as a CDMO.

  • Millipore sigma - As part of the Merck Group, Milipore sigma offers portfolio of preparation, separation, filtration and monitoring products. The Millipore portfolio is an ecosystem of products that are endlessly developing to offer smart and easy for usage product range in cell culture systems Single and multi-use systems, filtration and concentrations, purification and separation, and detection and monitoring.

  • Avantor, Inc. - Avantor is a publicly held company established in 1904 with headquarters at Pennsylvania, U.S. The company serves in four markets: biopharma, healthcare, advanced technologies & applied materials, education & government. These businesses are provided across three major geographic regions; Europe, Americas, and AMEA with a workforce of 13,500 employees across 30 different nations. Avantor is one of the key market leading provider of critical service and products to its customers in the aforementioned four markets. The worlwide customers of Avantor are served through the flagship brands; NuSil, J.T. Baker, Macron Fine Chemicals, Purltan Products, BeneSphera, Rankem, Avantor by VWR and Poch. The company’s product portfolio is vast and is employed across various stages of research, development and production.

  • VWR International LLC - Avantor successfully completed the acquisitions of VWR International, LLC in November 2017 and since then VWR operates as a wholly-owned subsidiary of Avantor. VWR International, LLC is a U.S.-based company founded in 1852 that is engaged in the marketing and distribution of research laboratory solutions. VWR’s established supply channel and multiple customer relationships added an advantage to the operations of Avantor. Companies acquired by VWR are currently a part of Avantor. JM Separations, STI Components LLC, PAW BioScience Products, LLC, and Integra Companies, LLC were acquired by VWR and are now consolidated under one legal company- Avantor Fluid Handling, LLC. JM Separations was established in 1995 in the U.S. and offers single-use bags, tank liners, and other solutions used for fluid handling The company is engaged in designing and manufacturing single-use equipment for both upstream and downstream processing. It offers single-use solutions for media/buffer preparation, cell recovery, concentration, and diafiltration & chromatographic processes in all mAbs, vaccine, and pharmaceutical proteins.

  • Eppendorf SE - Eppendorf SE is a life sciences company that produces and presents services, instruments, and consumables for sample handling, cell handling, and liquid handling in laboratories. Its product portfolio involves ultra-low temperature freezers, mixers, dispensers, shakers, fermenters, spectrometers, DNA amplification equipment, centrifuges, pipettes & automated pipetting systems, bioreactors, CO2 incubators, and cell manipulation systems. The company provides products for next-generation sequencing, genome editing, cell biology, molecular biology, microbiology, bioprocessing R&D, stem cells, biofuels, verification of foreign DNA, antibody production, bioprocessing food, environmental aspects, biochemistry, and forensic DNA typing.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Single-use Bioprocessing Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Single-use Bioprocessing Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon